Hello friends and welcome to episode 808 of the Juicebox podcast.

Today we're going to be speaking with Adele. Her child was in the Teplismob trial.

Now this was recorded about five months ago or so. And since then,

Teplismob has been FDA approved and is now being sold under the brand name of TZIELD.

TZIELD. I don't know how they say it. TZIELD. TZIELD. TZIELD. Is the T silent? Is the Z silent?

Is it TZIELD. TZIELD. I don't know. Anyway, her kid was in the trial. It was a double blind study,

but I think you'll hear while we're talking that it seems like her kid got the drug during the trial.

If you don't know what double blind means, well, then that might not make much sense to you,

but you'll figure it out as you're listening. All right, let me just say this one will get started.

Nothing you hear on the Juicebox podcast should be considered advice medical or otherwise.

Always consult a physician before making any changes to your health care plan or becoming bold

with insulin. It just occurred to me that you might not know what Teplismob is.

After the music, I'll explain.

So back in like, I don't know, March or April of 2021, I had Francisco Leone on the show

in episode 452 called Learning About Teplismob. Now, Francisco is the co-founder of

Prevention Bio. He's like a PhD and a really great guy who came on and talked all about type 1 diabetes

and the work that the company was doing at that time, which was to potentially be bringing

Teplismob to market if they could get an FDA approved. Francisco's an immunologist and a self-described

autoimmune aficionado who is focused on eradicating autoimmune disease through early detection and

prevention. Anyway, he comes on and he tells us all about this drug that they think you'll have to

go listen to it. He holds off the onset of type 1 diabetes and we talked about other stuff.

It's a really good episode. Anyway, the drug got approved by the FDA and I'd like to see if I can

...